Context:
Researchers have developed a new genome-editing strategy called PERT (Prime Editing-mediated Readthrough of premature Termination codons) that can potentially treat multiple genetic disorders caused by nonsense mutations. The study, published in Nature, involved scientists from the Broad Institute, Harvard University, and the University of Minnesota.
Key Highlights:
What is the PERT Genome-Editing Strategy?
• PERT is a genome-editing technique designed to override premature stop signals in genes, allowing cells to produce complete functional proteins.
• It works by reprogramming transfer RNA (tRNA) genes so that they can bypass faulty genetic signals.
• This approach can potentially treat multiple diseases simultaneously, as many disorders arise from similar genetic mutations.
Scientific Breakthrough and Research Findings
• In laboratory experiments with cultured human cells, PERT achieved 60–80% editing efficiency, significantly higher than traditional methods.
• In a Hurler syndrome mouse model, the technique restored 1.7–7% of normal enzyme activity in vital organs.
• The method was also tested in cell models of Batten disease, Tay-Sachs disease, and Niemann-Pick type C1 disease, showing promising enzyme restoration.
Mechanism Behind the Technology
• Nonsense mutations introduce premature stop codons in DNA, stopping protein production early.
• PERT modifies a non-essential tRNA gene into a suppressor tRNA that reads through these faulty signals.
• Scientists engineered thousands of variants of four tRNA types — leucine, arginine, tyrosine, and serine — to improve suppression of premature stop signals.
Delivery Method and Safety Tests
• The editing system was delivered using AAV9 (Adeno-Associated Virus 9), a commonly used gene-therapy vector.
• Safety tests showed that PERT:
- Did not alter unrelated DNA regions
- Did not disrupt normal cellular activity
- Maintained normal protein production processes.
Challenges Before Clinical Use
• Efficient delivery to multiple organs and tissues.
• Ensuring long-term safety and stability of edits.
• Testing across diverse human genetic conditions.
Relevant Prelims Points:
- Nonsense Mutation
- A mutation that introduces a premature stop codon in DNA, halting protein synthesis early.
- Accounts for roughly 25% of disease-causing genetic mutations.
- tRNA (Transfer RNA)
- RNA molecule that translates genetic code into proteins by carrying amino acids during protein synthesis.
- Prime Editing
- A precise genome-editing technology capable of inserting, deleting, or replacing DNA sequences without cutting both strands of DNA.
- Uses prime-editing guide RNA (pegRNA) to direct edits.
- AAV9 (Adeno-Associated Virus 9)
- A harmless viral vector used in gene therapy to deliver genetic material into cells.
- Diseases linked to nonsense mutations include:
- Hurler syndrome
- Tay-Sachs disease
- Batten disease
- Niemann-Pick disease
Relevant Mains Points:
Significance of PERT Technology
- Breakthrough in Genetic Medicine
• A single editing strategy could address multiple genetic diseases, making therapies more efficient. - Precision Genome Editing
• Prime editing allows targeted DNA correction without extensive genome disruption. - Potential for Rare Disease Treatment
• Many rare diseases are caused by single-gene mutations, making them suitable targets for genome editing. - Advancing Biotechnology and Medical Research
• Strengthens the role of CRISPR-based technologies and gene therapy in future healthcare.
Challenges and Ethical Concerns
- Delivery barriers to reach specific tissues in the body.
• High cost and technical complexity of gene therapies.
• Ethical issues around genome manipulation.
• Need for robust clinical trials and regulatory oversight.
Way Forward:
- Expand clinical trials and translational research.
• Develop safer gene delivery systems and vectors.
• Establish strong bioethics and regulatory frameworks.
• Encourage collaboration between biotechnology firms, academia, and governments.
UPSC Relevance:
• GS Paper 3: Biotechnology, emerging technologies, health innovation.
• Important for questions on gene editing, CRISPR technologies, and genetic disorders.